Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,484 signal articles · 143 in last 24h · 154,336 total before filter · latest 43m ago
143last 24h
865last 7d
141● bullish (7d)
96● bearish (7d)
214publishers
AllMacro206Earnings104M&A124Regulatory21Product21Analyst19
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Boston Scientific Won’t Meet Guidance Due to Cyberattack
The Wall Street Journal16d agoneutral
Boston Scientific Won’t Meet Guidance Due to Cyberattack

Boston Scientific said it likely won’t meet its financial guidance due to the cyberattack that has disrupted its operations, sending shares of the medical-technology company down sharply in premarket trading.

Looking Ahead to the Q3 Earnings Season: What to Expect
Zacks20d agoneutral
Looking Ahead to the Q3 Earnings Season: What to Expect

2026 Q3 earnings for the S&P 500 index are expected to increase by +23% from the same period last year on +11.2% higher revenues, reflecting the 13th consecutive period of growth. Revisions for the period remain positive, a continuation of the trend we've seen over the past year.

Unum Group (UNM): Buy, Sell, or Hold Post Q2 Earnings?
StockStory20d agoneutral
Unum Group (UNM): Buy, Sell, or Hold Post Q2 Earnings?

Unum Group currently trades at $96.56 and has been a dream stock for shareholders. It’s returned 268% since September 2021, blowing past the S&P 500’s 69.5% gain. The company has also beaten the index over the past six months as its stock price is up 31.6%.

Littelfuse (LFUS): Buy, Sell, or Hold Post Q2 Earnings?
StockStory20d agoneutral
Littelfuse (LFUS): Buy, Sell, or Hold Post Q2 Earnings?

Over the past six months, Littelfuse has been a great trade, beating the S&P 500 by 11%. Its stock price has climbed to $414.70, representing a healthy 22.7% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Matthews (MATW): Buy, Sell, or Hold Post Q2 Earnings?
StockStory20d agoneutral
Matthews (MATW): Buy, Sell, or Hold Post Q2 Earnings?

Over the past six months, Matthews’s stock price fell to $21.11. Shareholders have lost 19.3% of their capital, which is disappointing considering the S&P 500 has climbed by 11.7%. This was partly due to its softer quarterly results and might have investors contemplating their next move.